Elevated plasma migration inhibitory factor in hypertension–hyperlipidemia patients correlates with impaired endothelial function

Migration inhibitory factor (MIF) has been shown to be critical in the pathology of early artherosclerosis; this article aim to investigate the plasma levels of MIF in hypertension plus hyperlipidemia patients. A total of 39 hypertension plus hyperlipidemia patients without any previous treatment we...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Boda, Ren, Chuan, Zu, Lingyun, Zheng, Lemin, Guo, Lijun, Gao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089108/
https://www.ncbi.nlm.nih.gov/pubmed/27787379
http://dx.doi.org/10.1097/MD.0000000000005207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089108/
https://www.ncbi.nlm.nih.gov/pubmed/27787379
http://dx.doi.org/10.1097/MD.0000000000005207

Ejemplares similares